APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multi-cancer Early Detection (MCED) Tests

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Multi-cancer Early Detection (MCED) Tests Industry Growth and Trends Forecast to 2032

15 April 2026124 pages

Choose your research edition.

Industry ResearchMulti-cancer Early Detection (MCED) Tests Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Multi-cancer Early Detection (MCED) Tests Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Multi-cancer Early Detection (MCED) Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multi-cancer Early Detection (MCED) Tests Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Multi-cancer Early Detection (MCED) Tests Market Analysis and Forecast 2026-2032239 pages · $4,950 USD

Market perspective

According to APO Research, the global Multi-cancer Early Detection (MCED) Tests market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Multi-cancer Early Detection (MCED) Tests is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Multi-cancer Early Detection (MCED) Tests is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multi-cancer Early Detection (MCED) Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Multi-cancer Early Detection (MCED) Tests market include Guardant Health, Exact Sciences, Freenome, Epiginomics AG, Bio-techne, ThriveEarlier Detection, GRAIL, Inc., CellMax life and Berry Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Multi-cancer Early Detection (MCED) Tests market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Multi-cancer Early Detection (MCED) Tests market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Multi-cancer Early Detection (MCED) Tests market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Multi-cancer Early Detection (MCED) Tests.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Multi-cancer Early Detection (MCED) Tests market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Multi-cancer Early Detection (MCED) Tests Market by Company

Guardant Health

Exact Sciences

Freenome

Epiginomics AG

Bio-techne

ThriveEarlier Detection

GRAIL, Inc.

CellMax life

Berry Genomics

Singlera Genomics

Geneseeq

BGI Genomics

Burning Rock Biotech Limited

New Horizon Health Limited

Yeasen Bio

Hangzhou Aoru Biotech

Amoy Diagnostics Co., Ltd.

Genetron Health

AnchorDx

Surexam Bio-Tech Co.,Ltd.

HaploX

HefeiLaierBiotechnologyCo.,Ltd

Multi-cancer Early Detection (MCED) Tests Segment by Type

ctDNA Detection

CTC Detection

Exosome Detection

Multi-cancer Early Detection (MCED) Tests Segment by Application

Medical Institutions

Physical Examination Centers

Multi-cancer Early Detection (MCED) Tests Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multi-cancer Early Detection (MCED) Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multi-cancer Early Detection (MCED) Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multi-cancer Early Detection (MCED) Tests.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Multi-cancer Early Detection (MCED) Tests companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Multi-cancer Early Detection (MCED) Tests Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Multi-cancer Early Detection (MCED) Tests Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Multi-cancer Early Detection (MCED) Tests Market Share by Region (2021-2026) Table 4. Global Multi-cancer Early Detection (MCED) Tests Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Multi-cancer Early Detection (MCED) Tests Market Share by Region (2027-2032) Table 6. Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Multi-cancer Early Detection (MCED) Tests Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Multi-cancer Early Detection (MCED) Tests Market Size Share by Type (2021-2026) Table 9. Global Multi-cancer Early Detection (MCED) Tests Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Multi-cancer Early Detection (MCED) Tests Market Size Share Forecasted by Type (2027-2032) Table 11. North America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Multi-cancer Early Detection (MCED) Tests Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Multi-cancer Early Detection (MCED) Tests Market Size Share by Application (2021-2026) Table 24. Global Multi-cancer Early Detection (MCED) Tests Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Multi-cancer Early Detection (MCED) Tests Market Size Share Forecasted by Application (2027-2032) Table 26. North America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Multi-cancer Early Detection (MCED) Tests Industry Trends Table 37. Multi-cancer Early Detection (MCED) Tests Industry Drivers Table 38. Multi-cancer Early Detection (MCED) Tests Industry Opportunities and Challenges Table 39. Multi-cancer Early Detection (MCED) Tests Industry Restraints Table 40. Global Multi-cancer Early Detection (MCED) Tests Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Multi-cancer Early Detection (MCED) Tests Revenue Market Share by Company (2021-2026) Table 42. Global Multi-cancer Early Detection (MCED) Tests Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Multi-cancer Early Detection (MCED) Tests Key Company Headquarters & Area Served Table 44. Global Multi-cancer Early Detection (MCED) Tests Company, Product Type & Application Table 45. Global Multi-cancer Early Detection (MCED) Tests Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Multi-cancer Early Detection (MCED) Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Guardant Health Company Information Table 49. Guardant Health Business Overview Table 50. Guardant Health Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Guardant Health Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 52. Guardant Health Recent Development Table 53. Exact Sciences Company Information Table 54. Exact Sciences Business Overview Table 55. Exact Sciences Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Exact Sciences Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 57. Exact Sciences Recent Development Table 58. Freenome Company Information Table 59. Freenome Business Overview Table 60. Freenome Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Freenome Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 62. Freenome Recent Development Table 63. Epiginomics AG Company Information Table 64. Epiginomics AG Business Overview Table 65. Epiginomics AG Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Epiginomics AG Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 67. Epiginomics AG Recent Development Table 68. Bio-techne Company Information Table 69. Bio-techne Business Overview Table 70. Bio-techne Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Bio-techne Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 72. Bio-techne Recent Development Table 73. ThriveEarlier Detection Company Information Table 74. ThriveEarlier Detection Business Overview Table 75. ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 77. ThriveEarlier Detection Recent Development Table 78. GRAIL, Inc. Company Information Table 79. GRAIL, Inc. Business Overview Table 80. GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 82. GRAIL, Inc. Recent Development Table 83. CellMax life Company Information Table 84. CellMax life Business Overview Table 85. CellMax life Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. CellMax life Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 87. CellMax life Recent Development Table 88. Berry Genomics Company Information Table 89. Berry Genomics Business Overview Table 90. Berry Genomics Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Berry Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 92. Berry Genomics Recent Development Table 93. Singlera Genomics Company Information Table 94. Singlera Genomics Business Overview Table 95. Singlera Genomics Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Singlera Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 97. Singlera Genomics Recent Development Table 98. Geneseeq Company Information Table 99. Geneseeq Business Overview Table 100. Geneseeq Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Geneseeq Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 102. Geneseeq Recent Development Table 103. BGI Genomics Company Information Table 104. BGI Genomics Business Overview Table 105. BGI Genomics Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. BGI Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 107. BGI Genomics Recent Development Table 108. Burning Rock Biotech Limited Company Information Table 109. Burning Rock Biotech Limited Business Overview Table 110. Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 112. Burning Rock Biotech Limited Recent Development Table 113. New Horizon Health Limited Company Information Table 114. New Horizon Health Limited Business Overview Table 115. New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 117. New Horizon Health Limited Recent Development Table 118. Yeasen Bio Company Information Table 119. Yeasen Bio Business Overview Table 120. Yeasen Bio Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Yeasen Bio Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 122. Yeasen Bio Recent Development Table 123. Hangzhou Aoru Biotech Company Information Table 124. Hangzhou Aoru Biotech Business Overview Table 125. Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 127. Hangzhou Aoru Biotech Recent Development Table 128. Amoy Diagnostics Co., Ltd. Company Information Table 129. Amoy Diagnostics Co., Ltd. Business Overview Table 130. Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 132. Amoy Diagnostics Co., Ltd. Recent Development Table 133. Genetron Health Company Information Table 134. Genetron Health Business Overview Table 135. Genetron Health Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Genetron Health Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 137. Genetron Health Recent Development Table 138. AnchorDx Company Information Table 139. AnchorDx Business Overview Table 140. AnchorDx Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. AnchorDx Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 142. AnchorDx Recent Development Table 143. Surexam Bio-Tech Co.,Ltd. Company Information Table 144. Surexam Bio-Tech Co.,Ltd. Business Overview Table 145. Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 147. Surexam Bio-Tech Co.,Ltd. Recent Development Table 148. HaploX Company Information Table 149. HaploX Business Overview Table 150. HaploX Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. HaploX Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 152. HaploX Recent Development Table 153. HefeiLaierBiotechnologyCo.,Ltd Company Information Table 154. HefeiLaierBiotechnologyCo.,Ltd Business Overview Table 155. HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Product Portfolio Table 157. HefeiLaierBiotechnologyCo.,Ltd Recent Development Table 158. North America Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2026) Table 161. North America Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Multi-cancer Early Detection (MCED) Tests Market Share Forecast by Country (2027-2032) Table 163. Europe Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2026) Table 166. Europe Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Multi-cancer Early Detection (MCED) Tests Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2026) Table 171. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Share Forecast by Country (2027-2032) Table 173. Latin America Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2026) Table 176. Latin America Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Multi-cancer Early Detection (MCED) Tests Market Share Forecast by Country (2027-2032) Table 178. Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2026) Table 181. Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Share Forecast by Country (2027-2032) Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Multi-cancer Early Detection (MCED) Tests Product Image Figure 3. Global Multi-cancer Early Detection (MCED) Tests Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032) & (US$ Million) Figure 5. Global Multi-cancer Early Detection (MCED) Tests Market Share by Region: 2025 VS 2032 Figure 6. Global Multi-cancer Early Detection (MCED) Tests Market Share by Region (2021-2032) Figure 7. North America Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. ctDNA Detection Image Figure 13. Global ctDNA Detection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. CTC Detection Image Figure 15. Global CTC Detection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Exosome Detection Image Figure 17. Global Exosome Detection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Multi-cancer Early Detection (MCED) Tests Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Multi-cancer Early Detection (MCED) Tests Market Share by Type 2025 VS 2032 Figure 20. North America Multi-cancer Early Detection (MCED) Tests Market Size Share by Type (2021-2032) Figure 21. Europe Multi-cancer Early Detection (MCED) Tests Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Share by Type (2021-2032) Figure 23. Latin America Multi-cancer Early Detection (MCED) Tests Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Share by Type (2021-2032) Figure 25. Medical Institutions Image Figure 26. Global Medical Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Physical Examination Centers Image Figure 28. Global Physical Examination Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Multi-cancer Early Detection (MCED) Tests Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Multi-cancer Early Detection (MCED) Tests Market Share by Application 2025 VS 2032 Figure 31. North America Multi-cancer Early Detection (MCED) Tests Market Size Share by Application (2021-2032) Figure 32. Europe Multi-cancer Early Detection (MCED) Tests Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Share by Application (2021-2032) Figure 34. Latin America Multi-cancer Early Detection (MCED) Tests Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Multi-cancer Early Detection (MCED) Tests Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Multi-cancer Early Detection (MCED) Tests Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Multi-cancer Early Detection (MCED) Tests Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032) Figure 41. Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Multi-cancer Early Detection (MCED) Tests Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032) Figure 44. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032) Figure 47. Latin America Multi-cancer Early Detection (MCED) Tests Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Multi-cancer Early Detection (MCED) Tests Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032) Figure 50. Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • ctDNA Detection
  • CTC Detection
  • Exosome Detection
Applications
  • Medical Institutions
  • Physical Examination Centers
Companies covered
  • Guardant Health
  • Exact Sciences
  • Freenome
  • Epiginomics AG
  • Bio-techne
  • ThriveEarlier Detection
  • GRAIL, Inc.
  • CellMax life
  • Berry Genomics
  • Singlera Genomics
  • Geneseeq
  • BGI Genomics
  • Burning Rock Biotech Limited
  • New Horizon Health Limited
  • Yeasen Bio
  • Hangzhou Aoru Biotech
  • Amoy Diagnostics Co., Ltd.
  • Genetron Health
  • AnchorDx
  • Surexam Bio-Tech Co.,Ltd.
  • HaploX
  • HefeiLaierBiotechnologyCo.,Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Multi-cancer Early Detection (MCED) Tests Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Multi-cancer Early Detection (MCED) Tests Market Size by Region (2021-2032)
  5. 1.4.1 Global Multi-cancer Early Detection (MCED) Tests Market Size by Region (2021-2026)
  6. 1.4.2 Global Multi-cancer Early Detection (MCED) Tests Market Size by Region (2027-2032)
  7. 1.5 Key Regions Multi-cancer Early Detection (MCED) Tests Market Size (2021-2032)
  8. 1.5.1 North America Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (2021-2032)
2 Multi-cancer Early Detection (MCED) Tests Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 ctDNA Detection
  3. 2.1.2 CTC Detection
  4. 2.1.3 Exosome Detection
  5. 2.2 Global Multi-cancer Early Detection (MCED) Tests Market Size by Type
  6. 2.2.1 Global Multi-cancer Early Detection (MCED) Tests Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Multi-cancer Early Detection (MCED) Tests Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Multi-cancer Early Detection (MCED) Tests Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Multi-cancer Early Detection (MCED) Tests Market Size by Regions
  10. 2.3.1 North America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Type (2021-2026)
3 Multi-cancer Early Detection (MCED) Tests Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical Institutions
  3. 3.1.2 Physical Examination Centers
  4. 3.2 Global Multi-cancer Early Detection (MCED) Tests Market Size by Application
  5. 3.2.1 Global Multi-cancer Early Detection (MCED) Tests Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Multi-cancer Early Detection (MCED) Tests Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Multi-cancer Early Detection (MCED) Tests Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Multi-cancer Early Detection (MCED) Tests Market Size by Regions
  9. 3.3.1 North America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Multi-cancer Early Detection (MCED) Tests Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Multi-cancer Early Detection (MCED) Tests Industry Trends
  2. 4.2 Multi-cancer Early Detection (MCED) Tests Industry Drivers
  3. 4.3 Multi-cancer Early Detection (MCED) Tests Industry Opportunities and Challenges
  4. 4.4 Multi-cancer Early Detection (MCED) Tests Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Multi-cancer Early Detection (MCED) Tests Revenue (2021-2026)
  2. 5.2 Global Multi-cancer Early Detection (MCED) Tests Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Multi-cancer Early Detection (MCED) Tests Key Company Headquarters & Area Served
  4. 5.4 Global Multi-cancer Early Detection (MCED) Tests Company, Product Type & Application
  5. 5.5 Global Multi-cancer Early Detection (MCED) Tests Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Multi-cancer Early Detection (MCED) Tests Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Multi-cancer Early Detection (MCED) Tests Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Multi-cancer Early Detection (MCED) Tests Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Guardant Health
  2. 6.1.1 Guardant Health Company Information
  3. 6.1.2 Guardant Health Business Overview
  4. 6.1.3 Guardant Health Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Guardant Health Multi-cancer Early Detection (MCED) Tests Product Portfolio
  6. 6.1.5 Guardant Health Recent Developments
  7. 6.2 Exact Sciences
  8. 6.2.1 Exact Sciences Company Information
  9. 6.2.2 Exact Sciences Business Overview
  10. 6.2.3 Exact Sciences Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Exact Sciences Multi-cancer Early Detection (MCED) Tests Product Portfolio
  12. 6.2.5 Exact Sciences Recent Developments
  13. 6.3 Freenome
  14. 6.3.1 Freenome Company Information
  15. 6.3.2 Freenome Business Overview
  16. 6.3.3 Freenome Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Freenome Multi-cancer Early Detection (MCED) Tests Product Portfolio
  18. 6.3.5 Freenome Recent Developments
  19. 6.4 Epiginomics AG
  20. 6.4.1 Epiginomics AG Company Information
  21. 6.4.2 Epiginomics AG Business Overview
  22. 6.4.3 Epiginomics AG Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Epiginomics AG Multi-cancer Early Detection (MCED) Tests Product Portfolio
  24. 6.4.5 Epiginomics AG Recent Developments
  25. 6.5 Bio-techne
  26. 6.5.1 Bio-techne Company Information
  27. 6.5.2 Bio-techne Business Overview
  28. 6.5.3 Bio-techne Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Bio-techne Multi-cancer Early Detection (MCED) Tests Product Portfolio
  30. 6.5.5 Bio-techne Recent Developments
  31. 6.6 ThriveEarlier Detection
  32. 6.6.1 ThriveEarlier Detection Company Information
  33. 6.6.2 ThriveEarlier Detection Business Overview
  34. 6.6.3 ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 ThriveEarlier Detection Multi-cancer Early Detection (MCED) Tests Product Portfolio
  36. 6.6.5 ThriveEarlier Detection Recent Developments
  37. 6.7 GRAIL, Inc.
  38. 6.7.1 GRAIL, Inc. Company Information
  39. 6.7.2 GRAIL, Inc. Business Overview
  40. 6.7.3 GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GRAIL, Inc. Multi-cancer Early Detection (MCED) Tests Product Portfolio
  42. 6.7.5 GRAIL, Inc. Recent Developments
  43. 6.8 CellMax life
  44. 6.8.1 CellMax life Company Information
  45. 6.8.2 CellMax life Business Overview
  46. 6.8.3 CellMax life Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 CellMax life Multi-cancer Early Detection (MCED) Tests Product Portfolio
  48. 6.8.5 CellMax life Recent Developments
  49. 6.9 Berry Genomics
  50. 6.9.1 Berry Genomics Company Information
  51. 6.9.2 Berry Genomics Business Overview
  52. 6.9.3 Berry Genomics Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Berry Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio
  54. 6.9.5 Berry Genomics Recent Developments
  55. 6.10 Singlera Genomics
  56. 6.10.1 Singlera Genomics Company Information
  57. 6.10.2 Singlera Genomics Business Overview
  58. 6.10.3 Singlera Genomics Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Singlera Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio
  60. 6.10.5 Singlera Genomics Recent Developments
  61. 6.11 Geneseeq
  62. 6.11.1 Geneseeq Company Information
  63. 6.11.2 Geneseeq Business Overview
  64. 6.11.3 Geneseeq Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Geneseeq Multi-cancer Early Detection (MCED) Tests Product Portfolio
  66. 6.11.5 Geneseeq Recent Developments
  67. 6.12 BGI Genomics
  68. 6.12.1 BGI Genomics Company Information
  69. 6.12.2 BGI Genomics Business Overview
  70. 6.12.3 BGI Genomics Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 BGI Genomics Multi-cancer Early Detection (MCED) Tests Product Portfolio
  72. 6.12.5 BGI Genomics Recent Developments
  73. 6.13 Burning Rock Biotech Limited
  74. 6.13.1 Burning Rock Biotech Limited Company Information
  75. 6.13.2 Burning Rock Biotech Limited Business Overview
  76. 6.13.3 Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Burning Rock Biotech Limited Multi-cancer Early Detection (MCED) Tests Product Portfolio
  78. 6.13.5 Burning Rock Biotech Limited Recent Developments
  79. 6.14 New Horizon Health Limited
  80. 6.14.1 New Horizon Health Limited Company Information
  81. 6.14.2 New Horizon Health Limited Business Overview
  82. 6.14.3 New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 New Horizon Health Limited Multi-cancer Early Detection (MCED) Tests Product Portfolio
  84. 6.14.5 New Horizon Health Limited Recent Developments
  85. 6.15 Yeasen Bio
  86. 6.15.1 Yeasen Bio Company Information
  87. 6.15.2 Yeasen Bio Business Overview
  88. 6.15.3 Yeasen Bio Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Yeasen Bio Multi-cancer Early Detection (MCED) Tests Product Portfolio
  90. 6.15.5 Yeasen Bio Recent Developments
  91. 6.16 Hangzhou Aoru Biotech
  92. 6.16.1 Hangzhou Aoru Biotech Company Information
  93. 6.16.2 Hangzhou Aoru Biotech Business Overview
  94. 6.16.3 Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Hangzhou Aoru Biotech Multi-cancer Early Detection (MCED) Tests Product Portfolio
  96. 6.16.5 Hangzhou Aoru Biotech Recent Developments
  97. 6.17 Amoy Diagnostics Co., Ltd.
  98. 6.17.1 Amoy Diagnostics Co., Ltd. Company Information
  99. 6.17.2 Amoy Diagnostics Co., Ltd. Business Overview
  100. 6.17.3 Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Amoy Diagnostics Co., Ltd. Multi-cancer Early Detection (MCED) Tests Product Portfolio
  102. 6.17.5 Amoy Diagnostics Co., Ltd. Recent Developments
  103. 6.18 Genetron Health
  104. 6.18.1 Genetron Health Company Information
  105. 6.18.2 Genetron Health Business Overview
  106. 6.18.3 Genetron Health Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Genetron Health Multi-cancer Early Detection (MCED) Tests Product Portfolio
  108. 6.18.5 Genetron Health Recent Developments
  109. 6.19 AnchorDx
  110. 6.19.1 AnchorDx Company Information
  111. 6.19.2 AnchorDx Business Overview
  112. 6.19.3 AnchorDx Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 AnchorDx Multi-cancer Early Detection (MCED) Tests Product Portfolio
  114. 6.19.5 AnchorDx Recent Developments
  115. 6.20 Surexam Bio-Tech Co.,Ltd.
  116. 6.20.1 Surexam Bio-Tech Co.,Ltd. Company Information
  117. 6.20.2 Surexam Bio-Tech Co.,Ltd. Business Overview
  118. 6.20.3 Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Surexam Bio-Tech Co.,Ltd. Multi-cancer Early Detection (MCED) Tests Product Portfolio
  120. 6.20.5 Surexam Bio-Tech Co.,Ltd. Recent Developments
  121. 6.21 HaploX
  122. 6.21.1 HaploX Company Information
  123. 6.21.2 HaploX Business Overview
  124. 6.21.3 HaploX Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 HaploX Multi-cancer Early Detection (MCED) Tests Product Portfolio
  126. 6.21.5 HaploX Recent Developments
  127. 6.22 HefeiLaierBiotechnologyCo.,Ltd
  128. 6.22.1 HefeiLaierBiotechnologyCo.,Ltd Company Information
  129. 6.22.2 HefeiLaierBiotechnologyCo.,Ltd Business Overview
  130. 6.22.3 HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 HefeiLaierBiotechnologyCo.,Ltd Multi-cancer Early Detection (MCED) Tests Product Portfolio
  132. 6.22.5 HefeiLaierBiotechnologyCo.,Ltd Recent Developments
7 North America
  1. 7.1 North America Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026)
  3. 7.3 North America Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026)
  3. 8.3 Europe Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026)
  3. 10.3 South America Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Multi-cancer Early Detection (MCED) Tests Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst